Page last updated: 2024-10-31

nafamostat and Arterial Occlusive Diseases

nafamostat has been researched along with Arterial Occlusive Diseases in 3 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moroi, K1
Shiomi, Y1
Kumano, H1
Ishimura, N1
Nishiwada, M1
Kizaki, Y1
Ueki, Y1
Yoshida, K1
Yano, M1
Matsumoto, K1
Miyake, S1
Tominaga, Y1
Eguchi, K1
Yano, K1
Kistler, EB1
Lefer, AM1
Hugli, TE1
Schmid-Schönbein, GW1

Other Studies

3 other studies available for nafamostat and Arterial Occlusive Diseases

ArticleYear
[Anesthesia for a patient with heparin-induced thrombocytopenia: a case report].
    Masui. The Japanese journal of anesthesiology, 1997, Volume: 46, Issue:8

    Topics: Aged; Anastomosis, Surgical; Anesthesia, Epidural; Anesthesia, Inhalation; Anticoagulants; Arterial

1997
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1999, Volume: 10, Issue:6

    Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin

1999
Plasma activation during splanchnic arterial occlusion shock.
    Shock (Augusta, Ga.), 2000, Volume: 14, Issue:1

    Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Benzamidines; Biological Factors; Cats; Celiac

2000